SS Innovations International (NASDAQ:SSII) Trading Down 8.2% - Should You Sell?

Key Points

• Shares dropped 8.2% to $4.39 (low $4.42) on Wednesday with ~47,332 shares traded, about 48% below average; the 50-day moving average is $4.55 versus the 200-day at $5.83.
• Analysts rate the stock a "Sell" (Weiss reaffirmed a "sell (e+)"), and the company shows weak fundamentals with a negative PE (-71.67), negative net margin (-28.54%) and negative ROE (-30.23%).
• Insiders have been buying: directors Timothy P. Adams and Frederic H. Moll acquired large blocks at ~$3.99, and insiders bought a total of 1.3M shares (~$5.2M) in the last three months.

SS Innovations International, Inc. (NASDAQ:SSII - Get Free Report) shares dropped 8.2% on Wednesday . The company traded as low as $4.42 and last traded at $4.39. Approximately 47,332 shares were traded during trading, a decline of 48% from the average daily volume of 90,546 shares. The stock had previously closed at $4.78.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of SS Innovations International in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of "Sell".

SS Innovations International Stock Performance

The company has a market capitalization of $861.00 million and a PE ratio of -71.67. The business's 50-day moving average is $4.55 and its 200-day moving average is $5.83.

SS Innovations International (NASDAQ:SSII - Get Free Report) last issued its quarterly earnings results on Tuesday, March 10th. The company reported ($0.01) earnings per share (EPS) for the quarter. SS Innovations International had a negative net margin of 28.54% and a negative return on equity of 30.23%. The business had revenue of $14.53 million for the quarter.

Insider Activity at SS Innovations International

In other news, Director Timothy P. Adams bought 300,000 shares of the firm's stock in a transaction on Friday, March 6th. The stock was acquired at an average cost of $3.99 per share, with a total value of $1,197,000.00. Following the completion of the acquisition, the director owned 5,331,902 shares of the company's stock, valued at approximately $21,274,288.98. This represents a 5.96% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frederic H. Moll bought 501,253 shares of the firm's stock in a transaction on Friday, March 6th. The stock was purchased at an average cost of $3.99 per share, with a total value of $1,999,999.47. Following the completion of the acquisition, the director directly owned 10,775,485 shares of the company's stock, valued at approximately $42,994,185.15. The trade was a 4.88% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 1,300,006 shares of company stock valued at $5,196,999 in the last three months.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of SSII. PNC Financial Services Group Inc. purchased a new position in SS Innovations International in the third quarter worth about $56,000. Jane Street Group LLC purchased a new position in SS Innovations International in the fourth quarter worth about $63,000. IFC & Insurance Marketing Inc. purchased a new position in SS Innovations International in the fourth quarter worth about $64,000. Goldman Sachs Group Inc. purchased a new position in SS Innovations International in the fourth quarter worth about $68,000. Finally, Envestnet Asset Management Inc. purchased a new position in SS Innovations International in the third quarter worth about $71,000.

SS Innovations International Company Profile

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.